More Chinese drugmakers are moving beyond GLP-1s, adopting new strategies to capture a larger share of the global diabetes market.

longevity.technology/news/more-ch...

#DiabetesInnovation #ChineseBiotech #GLP1Alternatives #Healthspan #longevity #PrecisionMedicine #MetabolicHealth #BiotechTrends

Chinese biotechs & assets, a Q&A with Kanya Rajangam, MD, PhD Recently, I had a conversation with Dr. Kanya Rajangam, to discuss current perceptions about Chinese biotech, opportunities, language challenges, and risks.

To explore the changing #globallandscape of #drugdevelopment, Vibe Bio co-founder and CEO Alok Tayi recently had a conversation with Dr. Kanya Rajangam about the potential for #Chinesebiotech assets and programs in the US market.

Learn more in this post: vibebio.com/blog/chinese...

Little-Known Chinese Company Shocks Pharma Industry with Breakthrough Drug Little-Known Chinese Biotech Shakes Up the Industry with Groundbreaking Cancer Drug China’s DeepSeek Sparks a Wave of Innovation Beyond Big

Little-Known Chinese Company Shocks Pharma Industry with Breakthrough Drug
#Biotech,#Pharmaceuticals #CancerTreatment #LungCancer #MedicalBreakthrough #CancerResearch #ChineseBiotech #Akeso#HealthcareInnovation #BiotechNews #DrugDiscovery #MedicalInnovation #CancerDrug #ClinicalTrials #FDAApproval